Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("OGREID D")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 26

  • Page / 2

Export

Selection :

  • and

THE KINETICS OF THE INTERACTION BETWEEN CYCLIC AMP AND THE REGULATORY MOIETY OF PROTEIN KINASE IIOGREID D; DOSKELAND SO.1981; FEBS LETT.; ISSN 0014-5793; NLD; DA. 1981; VOL. 129; NO 2; PP. 282-286; BIBL. 9 REF.Article

THE KINETICS OF ASSOCIATION OF CYCLIC AMP TO THE TWO TYPES OF BINDING SITES ASSOCIATED WITH PROTEIN KINASE II FROM BOVINE MYOCARDIUMOGREID D; DOSKELAND SO.1981; FEBS LETT.; ISSN 0014-5793; NLD; DA. 1981; VOL. 129; NO 2; PP. 287-292; BIBL. 17 REF.Article

EVIDENCE THAT CYCLIC NUCLEOTIDES ACTIVATING RABBIT MUSCLE PROTEIN KINASE I INTERACT WITH BOTH TYPES OF CAMP BINDING SITES ASSOCIATED WITH THE ENZYMEOGREID D; DOSKELAND SO; MILLER JP et al.1983; JOURNAL OF BIOLOGICAL CHEMISTRY; ISSN 0021-9258; USA; DA. 1983; VOL. 258; NO 2; PP. 1041-1049; BIBL. 42 REF.Article

Characterization of the interchain and intrachain interactions between the binding sites of the free regulatory moiety of protein kinase IDØSKELAND, S. O; ØGREID, D.The Journal of biological chemistry (Print). 1984, Vol 259, Num 4, pp 2291-2301, issn 0021-9258Article

Aldolase B A 149P mutation and hereditary fructose intolerance are not associated with sudden infant death syndromeAARSKOG, N. K; ØGREID, D.Acta paediatrica (Oslo). 1995, Vol 84, Num 8, pp 947-948, issn 0803-5253Article

EVIDENCE AGAINST A REQUIREMENT FOR PHOSPHOLIPID METHYLATION IN ADENYLATE CYCLASE ACTIVATION BY HORMONES. METHYLTRANSFERASE INHIBITORS DO NOT IMPAIR CYCLIC AMP ACCUMULATION INDUCED BY GLUCAGON OR BETA -ADRENERGIC AGENTS IN RAT HEPATOCYTESSCHANCHE JS; OGREID D; DOSKELAND SO et al.1982; FEBS LETT.; ISSN 0014-5793; NLD; DA. 1982; VOL. 138; NO 2; PP. 167-172; BIBL. 36 REF.Article

Low-frequency mutation of Ha-ras and Ki-ras oncogenes in transitional cell carcinoma of the bladderOLDERØY, G; DAEHLIN, L; ØGREID, D et al.Anticancer research. 1998, Vol 18, Num 4A, pp 2675-2678, issn 0250-7005Article

The effect of ligands of phenylalanine 4-monooxygenase on the cAMP-dependent phosphorylation of the enzymeDØSKELAND, A. P; DØSKELAND, S. O; ØGREID, D et al.The Journal of biological chemistry (Print). 1984, Vol 259, Num 18, pp 11242-11248, issn 0021-9258Article

Studies on the interactions between the cyclic nucleotide-binding sites of cGMP-dependent protein kinaseDØSKELAND, S. O; VINTERMYR, O. K; CORBIN, J. D et al.The Journal of biological chemistry (Print). 1987, Vol 262, Num 8, pp 3534-3540, issn 0021-9258Article

Myocardial cAMP and calcium levels in the calcium paradoxROTEVATN, S; JODALEN, H; RØLI, J et al.Basic research in cardiology. 1986, Vol 81, Num 4, pp 430-435, issn 0300-8428Article

Frequent mutations of the p53 gene in cutaneous melanoma of the nodular typeAKSLEN, L. A; MONSTAD, S. E; LARSEN, B et al.International journal of cancer. 1998, Vol 79, Num 1, pp 91-95, issn 0020-7136Article

(Rp)- and (Sp)-8-piperidino-adenosine 3'-5'-(cyclic)thiophosphates discriminate completely between site A and B of the regulatory subunits of cAMP-dependent protein kinase type I and IIØGREID, D; DOSTMANN, W; GENIESER, H.-G et al.European journal of biochemistry (Print). 1994, Vol 221, Num 3, pp 1089-1094, issn 0014-2956Article

Mutations that prevent cyclic nucleotide binding to binding sites A or B of type I cyclic AMP-dependent protein kinaseØGREID, D; DØSKELAND, S. O; GORMAN, K. B et al.The Journal of biological chemistry (Print). 1988, Vol 263, Num 33, pp 17397-17404, issn 0021-9258Article

Characterization of cyclic adenosine 3':5'-monophosphate-dependent protein kinase isozymes in normal and neoplastic fetal rat brain cellsEKANGER, R; ØGREID, D; EVJEN, O et al.Cancer research (Baltimore). 1985, Vol 45, Num 6, pp 2578-2583, issn 0008-5472Article

Comparison of the two classes of binding sites (A and B) of type I and type II cyclic-AMP-dependent protein kinases by using cyclic nucleotide analogsØGREID, D; EKANGER, R; SUVA, R. H et al.European journal of biochemistry (Print). 1989, Vol 181, Num 1, pp 19-31, issn 0014-2956Article

The separate estimation of cAMP intracellularly bound to the regulatory subunits of protein kinase I and II in glucagon-stimulated rat he;atocytesEKANGER, R; SAND, T.-E; ØGREID, D et al.The Journal of biological chemistry (Print). 1985, Vol 260, Num 6, pp 3393-3401, issn 0021-9258Article

Detection of lymph node micrometastases in colorectal cancerNORDGARD, O; ALOYSIUS, T. A; TODNEM, K et al.Scandinavian journal of gastroenterology. 2003, Vol 38, Num 2, pp 125-132, issn 0036-5521, 8 p.Article

Characterization of the cyclic adenosine 3':5'-monophosphate effector system in hormone-dependent and hormone-independent rat mammary carcinomasØGREID, D; YOON SANG CHO-CHUNG; EKANGER, R et al.Cancer research (Baltimore). 1987, Vol 47, Num 10, pp 2576-2582, issn 0008-5472Article

Studies of cGMP analog specificity and function of the two intrasubunit binding sites of cGMP-dependent protein kinaseCORBIN, J. D; ØGREID, D; MILLER, J. P et al.The Journal of biological chemistry (Print). 1986, Vol 261, Num 3, pp 1208-1214, issn 0021-9258Article

Activation of protein kinase isozymes by cyclic nucleotide analogs used singly or in combination: principles for optimizing the isozyme specificity of analog combinationsØGREID, D; EKANGER, R; SUVA, R. H et al.European journal of biochemistry (Print). 1985, Vol 150, Num 1, pp 219-227, issn 0014-2956Article

Chronomodulated capecitabine in combination with short-time oxaliplatin : a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracilQVORTRUP, C; YILMAZ, M; PFEIFFER, P et al.Annals of oncology. 2008, Vol 19, Num 6, pp 1154-1159, issn 0923-7534, 6 p.Article

Selective modulation of protein kinase isozymes by the site-selective analog 8-chloroadenosine 3',5'-cyclic monophosphate provides a biological means for control of human colon cancer cell growthALLY, S; TORTORA, G; CLAIR, T et al.Proceedings of the National Academy of Sciences of the United States of America. 1988, Vol 85, Num 17, pp 6319-6322, issn 0027-8424Article

Short-time infusion of oxaliplatin in combination with capecitabine (XELOX30) as second-line therapy in patients with advanced colorectal cancer after failure to irinotecan and 5-fluorouracilPFEIFFER, P; SØRBYE, H; QVORTRUP, C et al.Annals of oncology. 2006, Vol 17, Num 2, pp 252-258, issn 0923-7534, 7 p.Article

Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer riskRYBERG, D; SKAUG, V; HEWER, A et al.Carcinogenesis (New York. Print). 1997, Vol 18, Num 7, pp 1285-1289, issn 0143-3334Article

Derivatives of 1-β-D-ribofuranosylbenzimidazole 3',5'-phosphate that mimic the actions of adenosine 3',5'-phosphate (cAMP) and guanosine 2',5'-phosphate (cGMP)GENIESER, H.-G; WINKLER, E; RUCHAUD, S et al.Carbohydrate research. 1992, Vol 234, pp 217-235, issn 0008-6215Article

  • Page / 2